Tafenoquine Succinate is primarily used in the prevention and treatment of malaria. It is particularly effective against Plasmodium vivax, a common malaria parasite. The chemical works by targeting the liver stage of the parasite, preventing relapse of the disease. It is often administered as a single dose, making it a convenient option for travelers and individuals in malaria-endemic regions. Additionally, it is used in combination with other antimalarial drugs to enhance efficacy and reduce the risk of resistance. Tafenoquine Succinate is also being explored for its potential in treating other parasitic infections, although its primary application remains focused on malaria control.